Kamila Zlotosch
Primary Care · Durham, NHNPI 1205449337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 51.0% of the total. Reporting peaked in 2023 at $883 and has fallen 95.0% since, to $44 in 2025. Among primary care clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $57.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$851
- Bayer$147
- Neurocrine Biosciences, Inc.$132
- Novo Nordisk$110
- Axsome Therapeutics, Inc.$102
- Phathom Pharmaceuticals, Inc.$83
- plus $244 from 8 others
What the payments were for
- Food & beverage$1,668100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,668 in reported general payments places this provider in the 90th percentile of 31 primary care providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $4,831 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $1,085 |
| Chlorpromazine Hcl | 15 | $1,065 |
| Tamsulosin Hcl | 39 | $944 |
| Gabapentin | 26 | $928 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 21 | $597 |
| Glipizide | 24 | $592 |
| Tramadol Hcl | 22 | $438 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 12 | $436 |
| Mirtazapine | 13 | $436 |
| Oxycodone Hcl | 20 | $436 |
| Metformin Hcl | 28 | $429 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $359 |
| Amlodipine Besylate | 25 | $299 |
| Latanoprost | 14 | $285 |
Paid to pharmacies, not to this prescriber.
Other primary care in Durham
- Debra LearmonthDurham$23
- Jean SchwartzLebanon$9K
- Beena RajagopalNashua$6K
- Kathleen DevejianHampstead$3K
- Deborah JensenHopkinton$801
- Tina McGuirkNashua$760
- Jennifer TichichLaconia$709
- Melissa-Jo NasonConway$704
- Stephane CampagnaLittleton$680
- Emily GrattanSomersworth$647
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.